SCHEMBL22984271

SCHEMBL22984271

Cc1ccc2nc(C)c(C(=O)NCc3ccc4c(c3)OCCC4)n2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.54
HTT P42858 3/20 0.54
LMNA P02545 3/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
ALDH1A1 P00352 6/20 0.50
KDM4E B2RXH2 3/20 0.50
GAA P10253 3/20 0.50
MAPT P10636 1/20 0.46
PKM P14618 1/20 0.42
TDP1 Q9NUW8 2/20 0.40
RAB9A P51151 3/20 0.39
POLB P06746 1/20 0.39
CHRM4 P08173 2/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
NR1H4 Q96RI1 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
DGAT1 O75907 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22984256 0.94 SMN1; SMN2 (0.55) SMN1; SMN2HTTLMNAL3MBTL1ALDH1A1
SCHEMBL22984313 0.93 HTT (0.54) SMN1; SMN2HTTLMNAL3MBTL1ALDH1A1
SCHEMBL22984369 0.88 SMN1; SMN2 (0.66) SMN1; SMN2HTTLMNAL3MBTL1ALDH1A1
SCHEMBL22984245 0.87 HTT (0.55) SMN1; SMN2HTTLMNAL3MBTL1ALDH1A1
SCHEMBL22984270 0.81 SMN1; SMN2 (0.51) SMN1; SMN2HTTLMNAL3MBTL1ALDH1A1
SCHEMBL22984268 0.80 CYP2C9 (0.58) SMN1; SMN2HTTLMNAL3MBTL1ALDH1A1
SCHEMBL22984297 0.80 SMN1; SMN2 (0.54) SMN1; SMN2HTTLMNAL3MBTL1ALDH1A1
SCHEMBL19723639 0.80 KDM4E (0.58) SMN1; SMN2HTTLMNAL3MBTL1ALDH1A1
SCHEMBL19723637 0.79 ALDH1A1 (0.51) SMN1; SMN2HTTLMNAL3MBTL1ALDH1A1
SCHEMBL22984356 0.79 HTT (0.55) SMN1; SMN2HTTLMNAL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919888-B2 Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection UNIVERSITY OF NOTRE DAME DU LAC (US) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919888-B2 Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection BET1, BRD4, BRD3 SMN1; SMN2 3362/4885HTT 4525/4885LMNA 1620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.